LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis

BMC Neurology

Volumn 13, Issue , 2013, Pages

  García Martín, Elena ^a   Lorenzo Betancor, Oswaldo ^b,c   Martínez, Carmen ^a   Pastor, Pau ^b,c,d   Benito León, Julián ^d,e,f   Millán Pascual, Jorge ^g   Calleja, Patricia ^e   Díaz Sánchez, María ^e   Pisa, Diana ^h   Turpín Fenoll, Laura ^g   Alonso Navarro, Hortensia ⁱ   Ayuso Peralta, Lucía ^j   Torrecillas, Dolores ^j   Lorenzo, Elena ^b   Plaza Nieto, José Francisco ⁱ   Agúndez, José A G ^a   Jiménez Jiménez, Félix Javier ^i,j  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^g HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^h UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

ⁱ Hospital Universitario del Sureste de Madrid   (Spain)

^j UNIVERSITY OF ALCALÁ   (Spain)

more..

Author keywords

Genetic polymorphisms; Genetics; LINGO 1; Multiple sclerosis; Risk factors

Indexed keywords

GENOMIC DNA; LEUCINE RICH REPEAT AND IMMUNOGLOBULIN DOMAIN CONTAINING NOGO RECEPTOR INTERACTING PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84875916248     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-34     Document Type: Article

References (50)

1. Giordano M, D'Alfonso S, Momigliano-Richiardi P. Genetics of multiple sclerosis: linkage and association studies. Am J Pharmacogenomics 2002, 2:37-58. 10.2165/00129785-200202010-00004, 12083953.
2. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004, 3:104-110. 10.1016/S1474-4422(03)00663-X, 14747002.
3. Ramagopalan SV, Deluca GC, Degenhardt A, Ebers GC. The genetics of clinical outcome in multiple sclerosis. J Neuroimmunol 2008, 201-202:183-199.
4. Pugliatti M, Harbo HF, Holmoy T, Kampman MT, Myhr KM, Riise T, Wolfson C. Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl 2008, 188:34-40.
5. Duque B, Sepulcre J, Bejarano B, Samaranch L, Pastor P, Villoslada P. Memory decline evolves independently of disease activity in MS. Mult Scler 2008, 14:947-953. 10.1177/1352458508089686, 18573817.
6. Baranzini SE. Revealing the genetic basis of multiple sclerosis: are we there yet?. Curr Opin Genet Dev 2011, 21:317-324. 10.1016/j.gde.2010.12.006, 3105160, 21247752.
7. Kemppinen A, Sawcer S, Compston A. Genome-wide association studies in multiple sclerosis: lessons and future prospects. Brief Funct Genomics 2011, 10:61-70. 10.1093/bfgp/elr004, 21310812.
8. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. 10.1038/nature10251, 3182531, 21833088.
9. Lassmann H. Axonal injury in multiple sclerosis. J Neurol Neurosurg Psychiatry 2003, 74:695-697. 10.1136/jnnp.74.6.695, 1738488, 12754330.
10. Domeniconi M, Filbin MT. Overcoming inhibitors in myelin to promote axonal regeneration. J Neurol Sci 2005, 233:43-47. 10.1016/j.jns.2005.03.023, 15949495.
11. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005, 8:745-751. 10.1038/nn1460, 15895088.
12. Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, Pepinsky RB, Qiu M, Miller RH, Chan JR, Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci 2007, 27:220-225. 10.1523/JNEUROSCI.4175-06.2007, 17202489.
13. Carim-Todd L, Escarceller M, Estivill X, Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur J Neurosci 2003, 18:3167-3182. 10.1111/j.1460-9568.2003.03003.x, 14686891.
14. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004, 7:221-228. 10.1038/nn1188, 14966521.
15. Park JB, Yiu G, Kaneko S, Wang J, Chang J, He XL, Garcia KC, He Z. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005, 45:345-351. 10.1016/j.neuron.2004.12.040, 15694321.
16. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, Thill G, Levesque M, Sah D, McCoy JM. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005, 45:353-359. 10.1016/j.neuron.2004.12.050, 15694322.
17. Stefansson H, Steinberg S, Petursson H, Gustafsson O, Gudjonsdottir IH, Jonsdottir GA, Palsson ST, Jonsson T, Saemundsdottir J, Bjornsdottir G. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009, 41:277-279. 10.1038/ng.299, 19182806.
18. Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 2010, 16:109-111. 10.1016/j.parkreldis.2009.08.006, 2844122, 19720553.
19. Vilarino-Guell C, Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010, 11:401-408. 10.1007/s10048-010-0241-x, 20369371.
20. Deng H, Gu S, Jankovic J. LINGO1 variants in essential tremor and Parkinson's disease. Acta Neurol Scand 2012, 125:1-7.
21. Jimenez-Jimenez FJ, Garcia-Martin E, Lorenzo-Betancor O, Pastor P, Alonso-Navarro H, Agundez JA. LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. J Neurol Sci 2012, 317:52-57. 10.1016/j.jns.2012.02.030, 22425540.
22. Agundez JA, Lorenzo-Betancor O, Pastor P, Garcia-Martin E, Luengo A, Alonso-Navarro H, Jimenez-Jimenez FJ. LINGO1 rs9652490 and rs11856808 are not associated with the risk of Parkinson's disease: results of a meta-analysis. Parkinsonism Relat Disord 2012, 18:657-659. 10.1016/j.parkreldis.2011.09.005, 21955595.
23. Lorenzo-Betancor O, Samaranch L, Garcia-Martin E, Cervantes S, Agundez JA, Jimenez-Jimenez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E. LINGO1 gene analysis in Parkinson's disease phenotypes. Mov Disord 2011, 26:722-727. 10.1002/mds.23452, 21506150.
24. Lorenzo-Betancor O, Garcia-Martin E, Cervantes S, Agundez JA, Jimenez-Jimenez FJ, Alonso-Navarro H, Luengo A, Coria F, Lorenzo E, Irigoyen J, Pastor P. Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor. Eur J Neurol 2011, 18:1085-1089. 10.1111/j.1468-1331.2010.03251.x, 21219542.
25. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
26. Martinez C, Garcia-Martin E, Benito-Leon J, Calleja P, Diaz-Sanchez M, Pisa D, Alonso-Navarro H, Ayuso-Peralta L, Torrecilla D, Agundez JA, Jimenez-Jimenez FJ. Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis. Neuromolecular Med 2010, 12:217-223. 10.1007/s12017-009-8095-9, 19826962.
27. Garcia-Martin E, Martinez C, Benito-Leon J, Calleja P, Diaz-Sanchez M, Pisa D, Alonso-Navarro H, Ayuso-Peralta L, Torrecilla D, Agundez JA, Jimenez-Jimenez FJ. Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis. Eur J Neurol 2010, 17:335-338. 10.1111/j.1468-1331.2009.02720.x, 19538200.
28. Agundez JA, Arroyo R, Ledesma MC, Martinez C, Ladero JM, de Andres C, Jimenez-Jimenez FJ, Molina JA, Alvarez-Cermeno JC, Varela de Seijas E. Frequency of CYP2D6 allelic variants in multiple sclerosis. Acta Neurol Scand 1995, 92:464-467. 10.1111/j.1600-0447.1995.tb09614.x, 8750111.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
30. Pértega Diaz S, Pita Fernández S. Cálculo del poder estadístico de un estudio Cadernos de atención primaria 2003, 10:59-63.
31. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169. 10.1086/379378, 1180495, 14574645.
32. Agundez JA, Golka K, Martinez C, Selinski S, Blaszkewicz M, Garcia-Martin E. Unraveling ambiguous NAT2 genotyping data. Clin Chem 2008, 54:1390-1394. 10.1373/clinchem.2008.105569, 18664443.
33. Satoh J, Onoue H, Arima K, Yamamura T. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 2005, 64:129-138.
34. Satoh J, Tabunoki H, Yamamura T, Arima K, Konno H. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2007, 33:99-107.
35. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007, 13:1228-1233. 10.1038/nm1664, 17906634.
36. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, Zhang Y, Shields CB, Miklasz S, Shea D. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009, 65:304-315. 10.1002/ana.21581, 19334062.
37. Wu Y, Wang X, Xu W, Liu W, Fang F, Ding J, Song Y, Chen S. Genetic variation in LINGO-1 (rs9652490) and risk of Parkinson's disease: twelve studies and a meta-analysis. Neurosci Lett 2012, 522:67-72. 10.1016/j.neulet.2012.06.018, 22710005.
38. Annesi F, De Marco EV, Rocca FE, Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Tarantino P, De Mari M, Lamberti P. Association study between the LINGO1 gene and Parkinson's disease in the Italian population. Parkinsonism Relat Disord 2011, 17:638-641. 10.1016/j.parkreldis.2011.06.020, 21752692.
39. Radovica I, Inashkina I, Smeltere L, Vitols E, Jankevics E. Screening of 10 SNPs of LINGO1 gene in patients with essential tremor in the Latvian population. Parkinsonism Relat Disord 2012, 18:93-95. 10.1016/j.parkreldis.2011.06.006, 21741293.
40. Bourassa CV, Riviere JB, Dion PA, Bernard G, Diab S, Panisset M, Chouinard S, Dupre N, Fournier H, Raelson J. LINGO1 variants in the French-Canadian population. PLoS One 2011, 6:e16254. 10.1371/journal.pone.0016254, 3019170, 21264305.
41. Wu YW, Rong TY, Li HH, Xiao Q, Fei QZ, Tan EK, Ding JQ, Chen SD. Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians. Acta Neurol Scand 2011, 124:264-268. 10.1111/j.1600-0404.2010.01466.x, 21158743.
42. Wu YR, Tan EK, Chen CM, Kumar PM, Lee-Chen GJ, Chen ST. Genetic analysis of " leucine-rich repeat (LRR) and immunoglobulin (Ig) domain-containing, Nogo receptor-interacting protein-1 (LINGO1)" in two independent Chinese parkinson's disease populations. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:99-103.
43. Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S. LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett 2011, 487:174-176. 10.1016/j.neulet.2010.10.016, 20951767.
44. Zuo X, Jiang H, Guo JF, Yu RH, Sun QY, Hu L, Wang L, Yao LY, Shen L, Pan Q. Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese population. Neurosci Lett 2010, 481:69-72. 10.1016/j.neulet.2010.06.041, 20600614.
45. Klebe S, Thier S, Lorenz D, Nothnagel M, Schreiber S, Klein C, Hagenah J, Kasten M, Berg D, Srulijes K. LINGO1 is not associated with Parkinson's disease in German patients. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1173-1178.
46. Clark LN, Park N, Kisselev S, Rios E, Lee JH, Louis ED. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet 2010, 18:838-843. 10.1038/ejhg.2010.27, 2987362, 20372186.
47. Thier S, Lorenz D, Nothnagel M, Stevanin G, Durr A, Nebel A, Schreiber S, Kuhlenbaumer G, Deuschl G, Klebe S. LINGO1 polymorphisms are associated with essential tremor in Europeans. Mov Disord 2010, 25:717-723. 10.1002/mds.22887, 20310002.
48. Bialecka M, Kurzawski M, Tan EK, Drozdzik M. Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis. Neurosci Lett 2010, 472:53-55. 10.1016/j.neulet.2010.01.055, 20117178.
49. Haubenberger D, Hotzy C, Pirker W, Katzenschlager R, Brucke T, Zimprich F, Auff E, Zimprich A. Role of LINGO1 polymorphisms in Parkinson's disease. Mov Disord 2009, 24:2404-2407. 2798904, 19908305.
50. Tan EK, Teo YY, Prakash KM, Li R, Lim HQ, Angeles D, Tan LC, Au WL, Yih Y, Zhao Y. LINGO1 variant increases risk of familial essential tremor. Neurology 2009, 73:1161-1162. 10.1212/WNL.0b013e3181bacfc9, 2890998, 19805735.